โ ExplanationAdvancedIndustry Deep Dives โบ Technology & Software
Eli Lilly Drops Over 2% as Pharmaceutical Margins Face Scrutiny Amid Sector Rotation
Shares of pharmaceutical heavyweight Eli Lilly pulled back more than 2% in Wednesday trading, underperforming the broader market. Market participants are balancing ongoing commercial demand for metabolic therapies against shifting institutional capital flows and capital expenditure trends.
2mยท๐ 0